Abstract:Deletion of lyn, a Src-family tyrosine kinase expressed by B, myeloid, and dendritic cells (DCs), triggers lupus-like disease in mice, characterized by autoantibody production and renal immune complex deposition leading to chronic glomerulonephritis. B cells from these mice are hyperactive to antigen-receptor stimulation owing to a loss of inhibitory signaling mediated by Lyn kinase. The hyperactive B-cell responses are thought to underlie the development of autoimmunity in this model. Lyn-deficient mice also manifest significant myeloexpansion. To test the contribution of different immune cell types to the lupus-like disease in this model, we generated a lyn(flox/flox) transgenic mouse strain. To our surprise, when we crossed these mice to Cd11c-cre animals, generating DC-specific deletion of Lyn, the animals developed spontaneous B- and T-cell activation and subsequent production of autoantibodies and severe nephritis. Remarkably, the DC-specific Lyn-deficient mice also developed severe tissue inflammatory disease, which was not present in the global lyn(-/-) strain. Lyn-deficient DCs were hyperactivated and hyperresponsive to Toll-like receptor agonists and IL-1β. To test whether dysregulation of these signaling pathways in DCs contributed to the inflammatory/autoimmune phenotype, we crossed the lyn(f/f) Cd11c-cre(+) mice to myd88(f/f) animals, generating double-mutant mice lacking both Lyn and the adaptor protein myeloid differentiation factor 88 (MyD88) in DCs, specifically. Deletion of MyD88 in DCs alone completely reversed the inflammatory autoimmunity in the DC-specific Lyn-mutant mice. Thus, we demonstrate that hyperactivation of MyD88-dependent signaling in DCs is sufficient to drive pathogenesis of lupus-like disease, illuminating the fact that dysregulation in innate immune cells alone can lead to autoimmunity.

Optimization of the Irf8 +32-kb enhancer disrupts dendritic cell lineage segregation

Anatomy of a superenhancer

Transcription factor E2F1 suppresses dendritic cell maturation.

Transcriptional Programming of Dendritic Cells for Enhanced MHC Class II Antigen Presentation

Regulatory dendritic cells program generation of interleukin-4–producing alternative memory CD4 T cells with suppressive activity

Transcription factor E2F1 suppresses dendritic cell maturation. (167.3)

A lncRNA identifies IRF8 enhancer element in negative feedback control of dendritic cell differentiation

Synergistic and antagonistic activities of IRF8 and FOS enhancer pairs during an immune cell fate switch

Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation

Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineages.

Transcriptional regulation of dendritic cell development and function

Dendritic Cell SIRT1–HIF1α Axis Programs the Differentiation of CD4 + T Cells Through IL-12 and TGF-β1

Dendritic Cell-Specific Disruption of TGF-β Receptor II Leads to Altered Regulatory T Cell Phenotype and Spontaneous Multiorgan Autoimmunity.

Transcriptional Regulatory Logic Orchestrating Lymphoid and Myeloid Cell Fate Decisions

TRIM33 plays a critical role in regulating dendritic cell differentiation and homeostasis by modulating Irf8 and Bcl2l11 transcription

Foxp3 Enhancers Synergize to Maximize Regulatory T Cell Suppressive Capacity.

A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet

Differential activation profiles of multiple transcription factors during dendritic cell maturation.

Transcriptional control of dendritic cell development and functions

Cohesin-mediated chromatin remodeling controls the differentiation and function of conventional dendritic cells

Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development